Jason Hawkes
Dermatology · Portland, ORNPI 1356631873
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $938,022 of the $1,470,124 with a category attached, or 63.8%. It is spread thinly across 26 manufacturers, the largest accounting for just 19.1%. 2025 is the largest year on record at $603,245, more than ten times the $20,193 reported in 2019. Among dermatology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,096 payments — averaging $1341.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$281K
- E.r. Squibb & Sons, L.L.C.$250K
- Regeneron Healthcare Solutions, Inc.$227K
- UCB, Inc.$159K
- Johnson & Johnson$124K
- Novartis$117K
- plus $312K from 20 others
Across 34 payments — averaging $16,178 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$279K
- Sun Pharmaceutical Industries Inc.$225K
- Novartis$34K
- Pfizer$11K
- Sanofi$500
What the payments were for
- Consulting fees$413,34628%
- Speaking & faculty fees$938,02264%
- Travel & lodging$94,4556%
- Food & beverage$24,0632%
- Education$2390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 143 | $281,157 |
| E.r. Squibb & Sons, L.L.C. | 142 | $249,568 |
| Regeneron Healthcare Solutions, Inc. | 214 | $227,037 |
| UCB, Inc. | 165 | $158,828 |
| Johnson & Johnson | 95 | $124,297 |
| Novartis | 90 | $117,222 |
| Boehringer Ingelheim | 49 | $99,440 |
| Lilly USA, LLC | 46 | $67,908 |
| AbbVie | 22 | $27,877 |
| Organon | 25 | $23,665 |
| Boehringer Ingelheim International GmbH | 9 | $18,535 |
| Arcutis Biotherapeutics, Inc. | 28 | $16,602 |
| Galderma Laboratories, L.p. | 24 | $15,563 |
| Dermavant Sciences, Inc. | 8 | $11,020 |
| Blueprint Medicines Corporation | 2 | $8,423 |
| LEO Pharma Inc. | 10 | $7,991 |
| Janssen Scientific Affairs, LLC | 4 | $4,214 |
| Pfizer | 6 | $3,015 |
| Sun Pharmaceutical Industries Inc. | 2 | $2,815 |
| UCB SA | 1 | $2,250 |
| Incyte Corporation | 4 | $2,194 |
| Sanofi-aventis U.S. LLC | 2 | $199 |
| Regeneron | 2 | $129 |
| Organogenesis Inc. | 1 | $129 |
| Amgen | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,470,124 in reported general payments places this provider in the 95th percentile of 175 dermatology providers in Oregon.
Other dermatology in Portland
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Eric SimpsonPortland$1.4M
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
- Paul HaunPortland$85K
- Kathryn SchwarzenbergerPortland$34K
- Jon HanifinPortland$25K
- Phoebe RichPortland$17K
- Tracy FunkPortland$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.